Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma
Clinical trial NCT03458260 · COMPLETED
Trial details
- NCT number
- NCT03458260
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-26
- Primary completion
- 2024-12-24
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.